Calendar

pharmadog

Week of Sep 29, 2025

Oct 2, 2025approval331d agoLIDOCAINE HYDROCHLORIDE — FDA approvalInternational Medication Systems Ltd

Sponsor: ANTHEA PHARMA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 2, 2025approval331d agoPILOCARPINE HYDROCHLORIDE — FDA approvalPILOCARPINE HYDROCHLORIDE

Sponsor: FDC LTD. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →PILOCARPINE HYDROCHLORIDE →fda approvals ↗

Oct 2, 2025approval331d agoOSELTAMIVIR PHOSPHATE — FDA approvalF. Hoffmann-La Roche Ltd

Sponsor: ZHEJIANG POLY PHARM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 2, 2025approval331d agoMIRTAZAPINE — FDA approvalmirtazapine ODT

Sponsor: ANNORA PHARMA. Form: TABLET. Route: ORAL

full page →mirtazapine ODT →fda approvals ↗

Oct 2, 2025approval331d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: CHARTWELL MOLECULAR. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Oct 2, 2025approval331d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

Sponsor: CHARTWELL MOLECULAR. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Oct 2, 2025approval331d agoETRAVIRINE — FDA approvalETRAVIRINE

Sponsor: BIONPHARMA. Form: TABLET. Route: ORAL

full page →ETRAVIRINE →fda approvals ↗

Oct 3, 2025approval330d agoDEFLAZACORT — FDA approvalDEFLAZACORT

Sponsor: ZYDUS LIFESCIENCES. Form: SUSPENSION. Route: ORAL

full page →DEFLAZACORT →fda approvals ↗

Oct 3, 2025approval330d agoDOVONEX (CALCIPOTRIENE) — FDA approvalcalcipotriene

Sponsor: LEO PHARMA AS. Form: CREAM. Route: TOPICAL

full page →calcipotriene →fda approvals ↗

Oct 3, 2025approval330d agoNAPROXEN — FDA approvalNAPROXEN

Sponsor: AUROBINDO PHARMA. Form: SUSPENSION. Route: ORAL

full page →NAPROXEN →fda approvals ↗

Oct 3, 2025approval330d agoCLOMIPHENE CITRATE — FDA approvalCLOMIPHENE CITRATE

Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL

full page →CLOMIPHENE CITRATE →fda approvals ↗

Oct 3, 2025approval330d agoDOVONEX (CALCIPOTRIENE) — FDA approvalcalcipotriene

Sponsor: LEO PHARMA AS. Form: OINTMENT. Route: TOPICAL

full page →calcipotriene →fda approvals ↗

Oct 3, 2025approval330d agoXELODA (CAPECITABINE) — FDA approvalArmas Pharmaceuticals Inc

Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 3, 2025approval330d agoOMEPRAZOLE — FDA approvalomeprazole DR

Sponsor: DEXCEL PHARMA. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →omeprazole DR →fda approvals ↗

Oct 3, 2025approval330d agoDOCOSANOL — FDA approvalPL Developments Copiague LLC

Sponsor: DR REDDYS. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Oct 3, 2025approval330d agoAXTLE (PEMETREXED DIPOTASSIUM) — FDA approvalAXTLE

Sponsor: AVYXA HOLDINGS. Form: POWDER. Route: INTRAVENOUS

full page →AXTLE →fda approvals ↗

Oct 4, 2025approval329d agoZORYVE (ROFLUMILAST) — FDA approvalArcutis Biotherapeutics, Inc.

Sponsor: ARCUTIS. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Week of Oct 6, 2025

Oct 6, 2025approval327d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Oct 6, 2025approval

← prev

page 334 of 380

Week of Sep 29, 2025

Week of Oct 6, 2025